Skip to content

Clinical trials

Phase 4 Coronary Artery Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Coronary Artery Disease Phase: Phase 4 Country / region: Canada Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20032
20042
20064
20081
20092
20102
20114
20121
20132
20142
20151
20191
20211
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Terminated3
Unknown status3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cardiology Research UBC3
Ottawa Heart Institute Research Corporation3
Innovaderm Research Inc.2
Laval University2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2
University of Alberta2
Abbott Medical Devices1
Boca Raton Regional Hospital1
Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal1
Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Coronary Artery Disease29
Acute Coronary Syndrome4
Diabetes Mellitus, Type 24
Angina Pectoris2
Coronary Stenosis2
Heart Valve Diseases2
Myocardial Infarction2
Psoriasis2
Angina, Unstable1
Atherosclerosis1

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.